ArticleMolecular biology reports2019

Evaluation of the CRISPR/Cas9 directed mutant TP53 gene repairing effect in human prostate cancer cell line PC-3.

Muhammet Burak Batır et al.PubMed ↗Publisher ↗

No numbers read from the abstract.